| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kopran Limited (NSE: KOPRAN)
KOPRAN Technical Analysis
4
| As on 16th Apr 2024 KOPRAN SHARE Price closed @ 266.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 224.17 & Buy for SHORT-TERM with Stoploss of 260.70 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KOPRANSHARE Price
| Open | 258.80 | Change | Price | % |
| High | 269.20 | 1 Day | 7.20 | 2.77 |
| Low | 257.05 | 1 Week | -13.35 | -4.76 |
| Close | 266.95 | 1 Month | 7.30 | 2.81 |
| Volume | 239779 | 1 Year | 121.50 | 83.53 |
| 52 Week High 322.10 | 52 Week Low 98.35 | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.95 | -1.52% |
| YESBANK | 23.95 | 0.00% |
| ONGC | 283.15 | 1.18% |
| EXIDEIND | 459.80 | 12.41% |
| NHPC | 91.20 | 2.53% |
| IDFCFIRSTB | 82.70 | -0.06% |
| PNB | 128.55 | -3.24% |
| ZOMATO | 186.45 | -0.98% |
| DHANI | 48.00 | 15.38% |
| TATASTEEL | 160.05 | -0.50% |
NSE INDIA Top Gainers Stocks
| DSSL | 1131.95 | 20.00% |
| HINDMOTORS | 21.95 | 19.95% |
| WABAG | 923.90 | 15.50% |
| DHANI | 48.00 | 15.38% |
| BHAGERIA | 185.45 | 15.15% |
| AKASH | 40.95 | 13.43% |
| MARKSANS | 176.70 | 13.38% |
| EXIDEIND | 459.80 | 12.41% |
| JAGSNPHARM | 321.45 | 11.89% |
| SOTL | 542.55 | 10.85% |
NSE INDIA Top Losers Stocks
| KOPRAN Daily Charts |
KOPRAN Intraday Charts |
Whats New @ Bazaartrend |
KOPRAN Free Analysis |
|
|
KOPRAN Important Levels Intraday
| RESISTANCE | 290.36 |
| RESISTANCE | 282.85 |
| RESISTANCE | 278.21 |
| RESISTANCE | 273.57 |
| SUPPORT | 260.33 |
| SUPPORT | 255.69 |
| SUPPORT | 251.05 |
| SUPPORT | 243.54 |
KOPRAN Target April 2024
| 4th UP Target | 345.88 |
| 3rd UP Target | 314.79 |
| 2nd UP Target | 295.58 |
| 1st UP Target | 276.36 |
| 1st DOWN Target | 221.54 |
| 2nd DOWN Target | 202.32 |
| 3rd DOWN Target | 183.11 |
| 4th DOWN Target | 152.02 |
KOPRAN Weekly Target
| 4th UP Target | 318.53 |
| 3rd UP Target | 303.11 |
| 2nd UP Target | 293.58 |
| 1st UP Target | 284.05 |
| 1st DOWN Target | 256.85 |
| 2nd DOWN Target | 247.32 |
| 3rd DOWN Target | 237.79 |
| 4th DOWN Target | 222.37 |
KOPRAN Target2024
| 4th UP Target | 606.61 |
| 3rd UP Target | 489.44 |
| 2nd UP Target | 417.01 |
| 1st UP Target | 344.58 |
| 1st DOWN Target | 137.92 |
| 2nd DOWN Target | 65.49 |
| 3rd DOWN Target | -6.94 |
| 4th DOWN Target | -124.11 |
Kopran Limited ( NSE INDIA Symbol : KOPRAN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KOPRAN Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 26.91 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -73.48 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 23.31 | |
| 10 Day Avg Volume | Traded -54.22 % Less then 10 Day Average Volume | ||
KOPRAN Other Details
| Segment | BE | |
| Market Capital | 8935574528.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > | |
KOPRAN Address
 |
||
KOPRAN Latest News
KOPRAN Business Profile
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers finished dosage forms, including tablets, capsules, dry powder, suspension, and injectable in various therapeutic areas comprising cardiovascular, antidiabetic, gastrointestinal, pain management, drug for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, and antipeptic ulcer and gut. It also provides active pharmaceutical ingredients in the categories of anti-hypertensive, macrolide, neuromodulator, sterile cephalosporins, carbapenems, anti-acne, anti-infective, urological, anti-thrombotic, anti-ulcerant, anti-depressant. The company was incorporated in 1958 and is headquartered in Mumbai, India. Address: Parijat House, Mumbai, India, 400018
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service